Research ArticleBRIEF COMMUNICATION
C-X-C Motif Chemokine Receptor 4–Directed Scintigraphy Using [99mTc]Tc-Pentixatec in Primary Aldosteronism: A Proof-of-Concept Study
Johanna S. Enke, Kathrin Ritzel, Evelyn Asbach, Nic G. Reitsam, Bruno Märkl, Thomas Knösel, Denise Brüdgam, Malte Kircher, Christian H. Pfob, Ralph A. Bundschuh, Andreas Rinscheid, Bernd Nittbaur, Georgine Wienand, Margret Schottelius, Martin Reincke, Constantin Lapa and Alexander Dierks
Journal of Nuclear Medicine October 2024, 65 (10) 1640-1644; DOI: https://doi.org/10.2967/jnumed.124.268169
Johanna S. Enke
1Nuclear Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Germany;
Kathrin Ritzel
2Department of Medicine IV, Ludwig Maximilians University Hospital Munich, Munich, Germany;
Evelyn Asbach
2Department of Medicine IV, Ludwig Maximilians University Hospital Munich, Munich, Germany;
Nic G. Reitsam
3Pathology, Faculty of Medicine, University of Augsburg, Augsburg, Germany;
Bruno Märkl
3Pathology, Faculty of Medicine, University of Augsburg, Augsburg, Germany;
Thomas Knösel
4Institute of Pathology, Ludwig Maximilians University Hospital Munich, Munich, Germany;
Denise Brüdgam
2Department of Medicine IV, Ludwig Maximilians University Hospital Munich, Munich, Germany;
Malte Kircher
1Nuclear Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Germany;
Christian H. Pfob
1Nuclear Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Germany;
Ralph A. Bundschuh
1Nuclear Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Germany;
Andreas Rinscheid
5Medical Physics and Radiation Protection, University Hospital Augsburg, Augsburg, Germany;
Bernd Nittbaur
1Nuclear Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Germany;
Georgine Wienand
1Nuclear Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Germany;
Margret Schottelius
6Translational Radiopharmaceutical Sciences, Departments of Nuclear Medicine and Oncology, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland;
7AGORA, Pôle de recherche sur le cancer, Lausanne, Switzerland; and
8SCCL Swiss Cancer Center Leman, Lausanne, Switzerland
Martin Reincke
2Department of Medicine IV, Ludwig Maximilians University Hospital Munich, Munich, Germany;
Constantin Lapa
1Nuclear Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Germany;
Alexander Dierks
1Nuclear Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Germany;

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue 10
October 1, 2024
C-X-C Motif Chemokine Receptor 4–Directed Scintigraphy Using [99mTc]Tc-Pentixatec in Primary Aldosteronism: A Proof-of-Concept Study
Johanna S. Enke, Kathrin Ritzel, Evelyn Asbach, Nic G. Reitsam, Bruno Märkl, Thomas Knösel, Denise Brüdgam, Malte Kircher, Christian H. Pfob, Ralph A. Bundschuh, Andreas Rinscheid, Bernd Nittbaur, Georgine Wienand, Margret Schottelius, Martin Reincke, Constantin Lapa, Alexander Dierks
Journal of Nuclear Medicine Oct 2024, 65 (10) 1640-1644; DOI: 10.2967/jnumed.124.268169
C-X-C Motif Chemokine Receptor 4–Directed Scintigraphy Using [99mTc]Tc-Pentixatec in Primary Aldosteronism: A Proof-of-Concept Study
Johanna S. Enke, Kathrin Ritzel, Evelyn Asbach, Nic G. Reitsam, Bruno Märkl, Thomas Knösel, Denise Brüdgam, Malte Kircher, Christian H. Pfob, Ralph A. Bundschuh, Andreas Rinscheid, Bernd Nittbaur, Georgine Wienand, Margret Schottelius, Martin Reincke, Constantin Lapa, Alexander Dierks
Journal of Nuclear Medicine Oct 2024, 65 (10) 1640-1644; DOI: 10.2967/jnumed.124.268169
Jump to section
Related Articles
Cited By...
- No citing articles found.